Xechem International Inc. (fka XKEM)

[xZx]

hardasset, check out this post:

http://www.investorshub.com/boards/read_msg.asp?message_id=11510553

let's say this extremely conservative 100k patients figure you mentioned is correct, for initial production, instead of 4 million patients... that's 100k/4M = .025... so using the math below we get $10 x .025 = .25 per share. still a bargain at .03, wouldn't you say? i sure would! even if they are somehow limited to 100,000 patients (and i highly doubt this, i'm only playing your side of the argument).

as i posted earlier, i do think they will have a pharma partner to help crank out more medicine, very quickly if not overnight, when nigerian approval comes. in fact, why wouldn't XKEM be lining up manufacturing partners already?

i also find the .25 number insanely undervalued because typical biotechs have much higher mulitples, especially if they have no competition. orphan status allows XKEM to market their drug exclusively for 7 years! what do you think the pps will be a few days after the nigerian drug approval comes? probably .25 or higher. just a guess... but i'll bet you i'm right on the mark.

here's the text from the above link:


In Nigeria alone, there are 4,000,000 SCD patients.

NICOSAN™ $20/month (conservative) = $240/year

$240 x 4,000,000 scd patients = $960,000,000 US dollars.

Multiply by a Price to Sales Ratio ratio of 21.25
(the ratio of Market capitalization to Annual Revenue).

The industry average for Pharma is 21.25, which means, if XKEM had $10M in annual sales it should have a market cap of $212M.

Let's continue...

$960,000,000 * 21 = approx $20,000,000,000

Divide by the number of shares
(let's say 1.9 Billion, max float available at this time)

$20,000,000,000 / 1,900,000,000 = $10.00

Now let's say they only get to sell to 5% of the people.[/]

Why only 5 percent you ask ?
- difficulty to ramp up production at first ..
- not everyone can afford it

5% of $10.00 = .50 stock.. (easy 15 bagger)

Now add the the rest of Africa (another 5 million cases)

And now we are over a dollar.

Now add the rest of the world....

Getting the picture...

Still want to sell your stock under .25...

Oh yes let's not forget the rest of XKEM's portfolio of drugs.